Sign Up to like & get
recommendations!
0
Published in 2023 at "Journal of pediatric hematology/oncology"
DOI: 10.1097/mph.0000000000002660
Abstract: The outcomes of pediatric chronic myeloid leukemia (CML) have improved with the use of imatinib mesylate (IM). Multiple reports of growth deceleration with IM have raised concerns, necessitating careful monitoring and evaluation in children with…
read more here.
Keywords:
meta analysis;
effect;
effect height;
growth ... See more keywords